ATE482229T1 - Modifizierte allergene der ns-ltps-familie enthaltende fusionsproteine, deren verwendung und pharmazeutische zusammensetzung, die diese verbindungen enthält - Google Patents

Modifizierte allergene der ns-ltps-familie enthaltende fusionsproteine, deren verwendung und pharmazeutische zusammensetzung, die diese verbindungen enthält

Info

Publication number
ATE482229T1
ATE482229T1 AT05708860T AT05708860T ATE482229T1 AT E482229 T1 ATE482229 T1 AT E482229T1 AT 05708860 T AT05708860 T AT 05708860T AT 05708860 T AT05708860 T AT 05708860T AT E482229 T1 ATE482229 T1 AT E482229T1
Authority
AT
Austria
Prior art keywords
fusion proteins
ltps
family
compounds
pharmaceutical composition
Prior art date
Application number
AT05708860T
Other languages
English (en)
Inventor
Domenico Geraci
Angela Bonura
Paolo Colombo
Original Assignee
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche filed Critical Consiglio Nazionale Ricerche
Application granted granted Critical
Publication of ATE482229T1 publication Critical patent/ATE482229T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • A61K39/36Allergens from pollen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05708860T 2004-02-27 2005-02-28 Modifizierte allergene der ns-ltps-familie enthaltende fusionsproteine, deren verwendung und pharmazeutische zusammensetzung, die diese verbindungen enthält ATE482229T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000103A ITRM20040103A1 (it) 2004-02-27 2004-02-27 Proteine di fusione comprendenti allergeni della famiglia delle ns-ltps, loro usi e composizioni farmaceutiche che le comprendono.
PCT/IB2005/050714 WO2005085278A1 (en) 2004-02-27 2005-02-28 Fusion proteins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same

Publications (1)

Publication Number Publication Date
ATE482229T1 true ATE482229T1 (de) 2010-10-15

Family

ID=34917554

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05708860T ATE482229T1 (de) 2004-02-27 2005-02-28 Modifizierte allergene der ns-ltps-familie enthaltende fusionsproteine, deren verwendung und pharmazeutische zusammensetzung, die diese verbindungen enthält

Country Status (9)

Country Link
US (1) US20070178122A1 (de)
EP (1) EP1720900B1 (de)
AT (1) ATE482229T1 (de)
CA (1) CA2558660C (de)
DE (1) DE602005023712D1 (de)
ES (1) ES2354820T3 (de)
IL (1) IL177698A0 (de)
IT (1) ITRM20040103A1 (de)
WO (1) WO2005085278A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2307381B1 (es) 2006-04-12 2009-10-23 Bial Industrial Farmaceutica S.A. Proteinas quimericas hipoalergenicas pertenecientes a la familia de transportadoras de lipidos de parietaria judaica utiles para el tratami ento de alergias.
AT503690A1 (de) 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
ITPA20080007A1 (it) 2008-03-19 2009-09-20 Angela Bonura Fattore anti - lps da parietaria judaica e suoi metodi di utilizzo.
ES2638271T3 (es) 2008-03-25 2017-10-19 Bial Industrial Farmaceutica, S.A. Proteínas híbridas hipoalergénicas de alérgenos de ácaros del grupo 1 y 2 principales para uso en el tratamiento de alergias
IT1395735B1 (it) * 2009-08-04 2012-10-19 Lofarma Spa Proteina ibrida ipoallergenica e suoi usi

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317905B1 (it) * 2000-09-11 2003-07-15 Consiglio Nazionale Ricerche Varianti di allergeni ns-ltps, loro usi e composizioni che lecomprendono.
ITRM20030247A1 (it) * 2003-05-20 2004-11-21 Bonura Angela Varianti ipoallergeniche degli allergeni maggiori

Also Published As

Publication number Publication date
EP1720900B1 (de) 2010-09-22
EP1720900A1 (de) 2006-11-15
US20070178122A1 (en) 2007-08-02
DE602005023712D1 (de) 2010-11-04
WO2005085278A1 (en) 2005-09-15
IL177698A0 (en) 2006-12-31
ES2354820T3 (es) 2011-03-18
ITRM20040103A1 (it) 2004-05-27
CA2558660C (en) 2015-07-14
CA2558660A1 (en) 2005-09-15

Similar Documents

Publication Publication Date Title
EA200602062A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
ECSP13012609A (es) Composición farmacéutica
CR11042A (es) Anticuerpos ox40 antagonistas y su uso en el tratamiento de enfermedades inflamatorias y autoinmunes
EA200700118A1 (ru) Амидосоединения и их применение в качестве лекарственных средств
EA200601897A1 (ru) Производные тетрагидронафтиридина, пригодные в качестве лигандов рецептора н3 гистамина
BR112015014751A8 (pt) anti-corpos anti-tau humanos e fragmento de ligação a tau dos mesmo, seu uso na preparação de um medicamento, bem como polipeptídeos codificando os mesmos.
DE60332358D1 (de) Protease-resistente modifizierte interferon alpha polypeptide
BRPI0514230A (pt) compostos de amido e seu uso como produtos farmacêuticos
BR122013025375B8 (pt) compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
BRPI0513850A (pt) composição terapêutica com uma neurotoxina botulìnica
AR092779A1 (es) Composicon farmaceutica que comprende anticuerpos que se unen a conformeros de proteinas tau
EA200701511A1 (ru) Фармацевтические композиции бендамустина, предназначенные для лиофилизации
CY1109624T1 (el) Υποκατεστημενα παραγωγα θειοφαινιου ως ανταγωνιστες υποδοχεα γλυκογονου, παρασκευη και θεραπευτικες χρησεις
EA200700117A1 (ru) N-замещенные пиперидины и их применение в качестве фармацевтических препаратов
ATE459619T1 (de) Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung
BR112015012366A8 (pt) antagonistas de cxcr7, uso dos mesmos, composição farmacêutica, bem como métodos para detectar níveis elevados de cxcr7 em uma amostra e para imagear um tumor, órgão, ou tecido
BRPI0514124B8 (pt) anticorpos monoclonais específicos para il-4 humana, seu uso, composição farmacêutica que os comprende e polinucleotídeos
ATE413167T1 (de) Neuartige biaromatische ppar-rezeptoren aktivierende zusammensetzungen und ihre verwendung in kosmetischen oder pharmazeutischen zusammensetzungen
TN2009000095A1 (en) Thiazole pyrazolopyrimidines as crf1 receptor antagonists
BRPI0410495A (pt) composição para o tratamento de uma doença inflamatória dos intestinos e uso de um antagonista de interferon tipo i para preparar um medicamento
HRP20050585A2 (en) Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof
SI2542257T1 (en) Optimized monoclonal antibodies against Tissue Factor Pathway Inhibitor (TFPI)
ATE384727T1 (de) Pyrimdobenzimidazolderivate und verwendung damit als agonisten oder antagonisten von melanocortinrezeptoren
ATE473961T1 (de) Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties